Reduction of interstitial fluid pressure after TNF-alpha treatment of three human melanoma xenografts

This publication has 17 references indexed in Scilit:

• Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery.
  1995
• Interstitial Fluid Pressure in Human Melanoma Xenografts Relationship to fractional tumor water content, tumor size, and tumor volume-doubling time
  Acta Oncologica, 1995
• Tumor‐necrosis factor can enhance radio‐antibody uptake in human colon carcinoma xenografts by increasing vascular permeability
  International Journal of Cancer, 1993
• Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse.
  1992
• High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma.
  Journal of Clinical Oncology, 1992
• Interstitial hypertension in superficial metastatic melanomas in humans.
  1991
• NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.
  Proceedings of the National Academy of Sciences, 1990
• Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
  Nature, 1987
• The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors.
  Proceedings of the National Academy of Sciences, 1987
• Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
  The Journal of Immunology, 1987